[Federal Register Volume 59, Number 240 (Thursday, December 15, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-30866]


[[Page Unknown]]

[Federal Register: December 15, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 94N-0392]

 

Fujisawa USA, Inc.; Withdrawal of Approval of a New Drug 
Application; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice, correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of November 3, 1994 (59 FR 
55120). The document withdrew approval of a new drug application (NDA) 
held by Fujisawa USA, Inc. The document was published with an 
inadvertent error. This document corrects that error.

EFFECTIVE DATE: November 3, 1994.

FOR FURTHER INFORMATION CONTACT: LaJuana D. Caldwell, Office of Policy 
(HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 
20857, 301-443-2994.
SUPPLEMENTARY INFORMATION: In FR Doc. 94-27317 appearing on page 55120 
in the Federal Register of Thursday, November 3, 1994, the following 
correction is made:
1. On page 55120, in the first column, in the fifth paragraph, line 6, 
the word ``Lyphomed'' is corrected to read ``Fujisawa''.

    Dated: December 9, 1994.
William K. Hubbard,
Interim Deputy Commissioner for Policy.
[FR Doc. 94-30866 Filed 12-14-94; 8:45 am]
BILLING CODE 4160-01-F